An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Butterfly Network to Present at the 42nd Annual Cowen Health Care Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will participate in Cowen's 42nd Annual Health Care Conference from March 7-9, 2022. CEO Dr. Todd Fruchterman is scheduled for a virtual fireside chat on March 9 at 10:30 AM ET. A live webcast and archived recording will be accessible via the Butterfly Network investor website. Founded in 2011, Butterfly Network revolutionizes medical imaging with its handheld ultrasound technology, aiming for health equity worldwide. Its products, Butterfly iQ+ and Butterfly iQ+ Vet, are available for purchase across multiple countries.
Positive
None.
Negative
None.
GUILFORD, Conn. & NEW YORK--(BUSINESS WIRE)--
Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), today announced that it will participate in Cowen’s 42nd Annual Health Care Conference to be held virtually on March 7-9, 2022. Dr. Todd Fruchterman, President and CEO will participate in a virtual fireside chat on Wednesday, March 9, 2022, at 10:30 am Eastern Time.
A live webcast of the fireside chat and an archived recording will be available in the Events & Presentations section of the Butterfly Network investor website.
About Butterfly Network, Inc.
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network has created the world’s first handheld, single-probe whole-body ultrasound system using its patented Ultrasound-on-Chip™ semiconductor technology. Butterfly’s mission is to democratize medical imaging and contribute to the aspiration of global health equity, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ+ and Butterfly iQ+ Vet can be purchased today by healthcare practitioners and veterinarians, respectively, in the United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom. Butterfly iQ+ is a prescription device intended for qualified healthcare professionals only. For more information, visit www.butterflynetwork.com.
When is Butterfly Network's participation in Cowen's 42nd Annual Health Care Conference?
Butterfly Network will participate in Cowen's 42nd Annual Health Care Conference from March 7-9, 2022.
What time will the CEO of Butterfly Network speak at the conference?
Dr. Todd Fruchterman, CEO of Butterfly Network, will speak during a virtual fireside chat on March 9, 2022, at 10:30 AM ET.
Where can I watch the Butterfly Network conference presentation?
You can watch the live webcast and access the archived recording on the Butterfly Network investor website.
What products does Butterfly Network offer?
Butterfly Network offers the Butterfly iQ+ and Butterfly iQ+ Vet ultrasound systems for healthcare professionals and veterinarians.
What is the mission of Butterfly Network?
Butterfly Network aims to democratize medical imaging and improve global health equity, addressing the needs of 4.7 billion people lacking access to ultrasound.
What technology does Butterfly Network use in its products?
Butterfly Network uses patented Ultrasound-on-Chip™ semiconductor technology in its handheld ultrasound systems.
